CytoSen Therapeutics appoints Reata Pharmaceuticals CFO to board: 3 notes

Private biopharmaceutical company CytoSen Therapeutics appointed Jason Wilson to the company's board of directors.

Three notes:

1. Mr. Wilson has more than two decades of corporate finance and life science operations experience.

2. He is currently CFO of Reata Pharmaceuticals, where he leads multiple areas, including corporate strategy, finance, accounting, treasury, investor relations, human resources and IT.

3. Mr. Wilson previously served as vice president of finance and corporate controller at Caris Diagnostics and senior manager in Ernst & Young's health-sciences group.


More articles on leadership and management:

CHI Health CEO: Hospital-owned drug company is perfect industry disruptor
Ousted California hospital board member resigns clinical privileges
4 tips for physicians who want to be good mentors

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Whitepapers

Featured Webinars